Acute hyponatraemia and 'ecstasy': Insights from a quantitative and integrative analysis

55Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 20-year-old woman attended a 'rave party' where she took the drug 3,4-methylenedioxy-methamphetamine (MDMA, 'ecstasy'). She had used this drug previously without serious adverse effects. On this occasion, while both she and her friends drank a large quantity of water, only she became seriously ill. The initial manifestation was an altered sensorium; several hours later she had a grand mal seizure. In the Emergency Department, the most striking features were the severe degree of hyponatraemia (112 mmol/l) and cerebral oedema. To explain the basis for this life-threatening clinical presentation, an imaginary consultation was sought with Professor McCance. Using both a deductive and a quantitative analysis that involved several medical subspecialties, he illustrated that a simple story of water ingestion and vasopressin release was not sufficient to explain her hyponatraemia. It was only after events in her gastrointestinal tract were analysed that a plausible hypothesis could be constructed.

Cite

CITATION STYLE

APA

Cherney, D. Z. I., Davids, M. R., & Halperin, M. L. (2002). Acute hyponatraemia and “ecstasy”: Insights from a quantitative and integrative analysis. QJM: An International Journal of Medicine, 95(7), 475–483. https://doi.org/10.1093/qjmed/95.7.475

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free